Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$905K Hold
3,000
0.42% 47
2026
Q1
$442K Hold
3,000
0.23% 57
2025
Q4
$365K Hold
3,000
0.18% 63
2025
Q3
$324K Hold
3,000
0.16% 66
2025
Q2
$269K Hold
3,000
0.15% 69
2025
Q1
$204K Buy
+3,000
New +$216K 0.11% 75
2024
Q4
Sell
-3,000
Closed -$232K 98
2024
Q3
$232K Hold
3,000
0.12% 79
2024
Q2
$247K Hold
3,000
0.13% 75
2024
Q1
$210K Buy
+3,000
New +$193K 0.11% 79

Other funds holding KLAC

Lipe & Dalton's KLAC Position: Q2 2026 in Review

Lipe & Dalton held its KLA (KLAC) position steady in Q2 2026 at 3,000 shares worth $905K. The position accounts for 0.42% of the portfolio, ranked #47.

Lipe & Dalton first reported a position in KLAC in Q1 2024 and has held it in 9 quarters since. 1,126 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Lipe & Dalton held 3,000 shares of KLA worth $905K as of Q2 2026.
  • Lipe & Dalton left its KLA share count unchanged in Q2 2026.
  • KLA made up 0.42% of Lipe & Dalton's portfolio in Q2 2026, its #47 holding.
  • Lipe & Dalton first reported a position in KLA in Q1 2024 and has held it in 9 quarters since.
  • 1,126 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.